Weekly Commentary: Infestation

With Credit blowups pressuring markets, we'll now see the typical dynamic where news/analysis follows market direction. Read ...
Le Lézard

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...